Access to Life Improving
Pharmaceuticals
Core Benefits of
Improved Performance
Our needle-free solutions provide a similar, and in many cases, better immunogenicity. With a strong antibody and T-cell response, you won’t need to reformulate.
Faster to Market
We reduce your “go to market” risks. We bring commercialized platforms, comprehensive clearances and registrations, and global manufacturing capacity to your products.
Delighted Users
Our worldwide partner list is growing quickly. Our products result in a 90%+ user preference and an 18% increase in vaccination coverage (backed by data generated in over 20 countries).
Our Needle-free Systems
Partnership
You Can Trust
At PharmaJet, we are committed to bringing your vaccine to the world through a system that’s fast, safe, and easy-to-use. Our products hold WHO PQS certification and CE Mark for intradermal, intramuscular, and subcutaneous use. We believe that vaccines should be available to all, safe for everyone, and effective in the global fight against disease.
Here are just a few of our 50+ valued partners:
Becoming a partner is simple.
1. Discover What’s Possible
We’ll get to know you, your science, and the challenges you’re facing to advance your pipeline. If we find a good fit, we’ll put you on a proven pathway to get started quickly.
2. Customize Our Collaboration
We’ll work with you to create a customized plan to support everything from preclinical to clinical validation. We’ll share our experience and relevant data from 100 development programs so we can map out an efficient timeline.
3. Receive Expert Support
Our clinical experts will share our best-practice approaches tailored to your specific program. From pre-clinical through clinical study design, we’ll deliver technical support, product training, and guidance on regulatory compliance.
4. Advance Efficiently to Launch
Once our collaboration has created successful initial testing, we’ll collaborate on a customized and mutually beneficial commercialization agreement to help you complete your studies, submit regulatory authorities, and launch with confidence.